Markets
Mizuho Raises Amylyx Price Target to $24: What Traders Need to Know Before Trial Data Drops
Mizuho has raised its Amylyx Pharmaceuticals price target to $24, signalling renewed analyst conviction ahead of pivotal clinical trial results. Here's what the upgrade means for traders positioning now.